1 Study Coverage
    1.1 Intravenous Injection Immunoglobulin Product Introduction
    1.2 Market by Type
        1.2.1 Global Intravenous Injection Immunoglobulin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 1g/20ml
        1.2.3 1.25g/25ml
        1.2.4 2.5g/50ml
        1.2.5 5g/100ml
        1.2.6 10g/200ml
    1.3 Market by Application
        1.3.1 Global Intravenous Injection Immunoglobulin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Intravenous Injection Immunoglobulin Sales Estimates and Forecasts 2017-2028
    2.2 Global Intravenous Injection Immunoglobulin Revenue Estimates and Forecasts 2017-2028
    2.3 Global Intravenous Injection Immunoglobulin Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Intravenous Injection Immunoglobulin Sales by Region
        2.4.1 Global Intravenous Injection Immunoglobulin Sales by Region (2017-2022)
        2.4.2 Global Sales Intravenous Injection Immunoglobulin by Region (2023-2028)
    2.5 Global Intravenous Injection Immunoglobulin Revenue by Region
        2.5.1 Global Intravenous Injection Immunoglobulin Revenue by Region (2017-2022)
        2.5.2 Global Intravenous Injection Immunoglobulin Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Intravenous Injection Immunoglobulin Sales by Manufacturers
        3.1.1 Global Top Intravenous Injection Immunoglobulin Manufacturers by Sales (2017-2022)
        3.1.2 Global Intravenous Injection Immunoglobulin Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Intravenous Injection Immunoglobulin in 2021
    3.2 Global Intravenous Injection Immunoglobulin Revenue by Manufacturers
        3.2.1 Global Intravenous Injection Immunoglobulin Revenue by Manufacturers (2017-2022)
        3.2.2 Global Intravenous Injection Immunoglobulin Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Intravenous Injection Immunoglobulin Revenue in 2021
    3.3 Global Intravenous Injection Immunoglobulin Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Intravenous Injection Immunoglobulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Intravenous Injection Immunoglobulin Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Intravenous Injection Immunoglobulin Sales by Type
        4.1.1 Global Intravenous Injection Immunoglobulin Historical Sales by Type (2017-2022)
        4.1.2 Global Intravenous Injection Immunoglobulin Forecasted Sales by Type (2023-2028)
        4.1.3 Global Intravenous Injection Immunoglobulin Sales Market Share by Type (2017-2028)
    4.2 Global Intravenous Injection Immunoglobulin Revenue by Type
        4.2.1 Global Intravenous Injection Immunoglobulin Historical Revenue by Type (2017-2022)
        4.2.2 Global Intravenous Injection Immunoglobulin Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Intravenous Injection Immunoglobulin Revenue Market Share by Type (2017-2028)
    4.3 Global Intravenous Injection Immunoglobulin Price by Type
        4.3.1 Global Intravenous Injection Immunoglobulin Price by Type (2017-2022)
        4.3.2 Global Intravenous Injection Immunoglobulin Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Intravenous Injection Immunoglobulin Sales by Application
        5.1.1 Global Intravenous Injection Immunoglobulin Historical Sales by Application (2017-2022)
        5.1.2 Global Intravenous Injection Immunoglobulin Forecasted Sales by Application (2023-2028)
        5.1.3 Global Intravenous Injection Immunoglobulin Sales Market Share by Application (2017-2028)
    5.2 Global Intravenous Injection Immunoglobulin Revenue by Application
        5.2.1 Global Intravenous Injection Immunoglobulin Historical Revenue by Application (2017-2022)
        5.2.2 Global Intravenous Injection Immunoglobulin Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Intravenous Injection Immunoglobulin Revenue Market Share by Application (2017-2028)
    5.3 Global Intravenous Injection Immunoglobulin Price by Application
        5.3.1 Global Intravenous Injection Immunoglobulin Price by Application (2017-2022)
        5.3.2 Global Intravenous Injection Immunoglobulin Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Intravenous Injection Immunoglobulin Market Size by Type
        6.1.1 North America Intravenous Injection Immunoglobulin Sales by Type (2017-2028)
        6.1.2 North America Intravenous Injection Immunoglobulin Revenue by Type (2017-2028)
    6.2 North America Intravenous Injection Immunoglobulin Market Size by Application
        6.2.1 North America Intravenous Injection Immunoglobulin Sales by Application (2017-2028)
        6.2.2 North America Intravenous Injection Immunoglobulin Revenue by Application (2017-2028)
    6.3 North America Intravenous Injection Immunoglobulin Market Size by Country
        6.3.1 North America Intravenous Injection Immunoglobulin Sales by Country (2017-2028)
        6.3.2 North America Intravenous Injection Immunoglobulin Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Intravenous Injection Immunoglobulin Market Size by Type
        7.1.1 Europe Intravenous Injection Immunoglobulin Sales by Type (2017-2028)
        7.1.2 Europe Intravenous Injection Immunoglobulin Revenue by Type (2017-2028)
    7.2 Europe Intravenous Injection Immunoglobulin Market Size by Application
        7.2.1 Europe Intravenous Injection Immunoglobulin Sales by Application (2017-2028)
        7.2.2 Europe Intravenous Injection Immunoglobulin Revenue by Application (2017-2028)
    7.3 Europe Intravenous Injection Immunoglobulin Market Size by Country
        7.3.1 Europe Intravenous Injection Immunoglobulin Sales by Country (2017-2028)
        7.3.2 Europe Intravenous Injection Immunoglobulin Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Intravenous Injection Immunoglobulin Market Size by Type
        8.1.1 Asia Pacific Intravenous Injection Immunoglobulin Sales by Type (2017-2028)
        8.1.2 Asia Pacific Intravenous Injection Immunoglobulin Revenue by Type (2017-2028)
    8.2 Asia Pacific Intravenous Injection Immunoglobulin Market Size by Application
        8.2.1 Asia Pacific Intravenous Injection Immunoglobulin Sales by Application (2017-2028)
        8.2.2 Asia Pacific Intravenous Injection Immunoglobulin Revenue by Application (2017-2028)
    8.3 Asia Pacific Intravenous Injection Immunoglobulin Market Size by Region
        8.3.1 Asia Pacific Intravenous Injection Immunoglobulin Sales by Region (2017-2028)
        8.3.2 Asia Pacific Intravenous Injection Immunoglobulin Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Intravenous Injection Immunoglobulin Market Size by Type
        9.1.1 Latin America Intravenous Injection Immunoglobulin Sales by Type (2017-2028)
        9.1.2 Latin America Intravenous Injection Immunoglobulin Revenue by Type (2017-2028)
    9.2 Latin America Intravenous Injection Immunoglobulin Market Size by Application
        9.2.1 Latin America Intravenous Injection Immunoglobulin Sales by Application (2017-2028)
        9.2.2 Latin America Intravenous Injection Immunoglobulin Revenue by Application (2017-2028)
    9.3 Latin America Intravenous Injection Immunoglobulin Market Size by Country
        9.3.1 Latin America Intravenous Injection Immunoglobulin Sales by Country (2017-2028)
        9.3.2 Latin America Intravenous Injection Immunoglobulin Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Intravenous Injection Immunoglobulin Market Size by Type
        10.1.1 Middle East and Africa Intravenous Injection Immunoglobulin Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Intravenous Injection Immunoglobulin Revenue by Type (2017-2028)
    10.2 Middle East and Africa Intravenous Injection Immunoglobulin Market Size by Application
        10.2.1 Middle East and Africa Intravenous Injection Immunoglobulin Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Intravenous Injection Immunoglobulin Revenue by Application (2017-2028)
    10.3 Middle East and Africa Intravenous Injection Immunoglobulin Market Size by Country
        10.3.1 Middle East and Africa Intravenous Injection Immunoglobulin Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Intravenous Injection Immunoglobulin Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Boya-Bio
        11.1.1 Boya-Bio Corporation Information
        11.1.2 Boya-Bio Overview
        11.1.3 Boya-Bio Intravenous Injection Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Boya-Bio Intravenous Injection Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Boya-Bio Recent Developments
    11.2 Beijing Tiantan Biological Products
        11.2.1 Beijing Tiantan Biological Products Corporation Information
        11.2.2 Beijing Tiantan Biological Products Overview
        11.2.3 Beijing Tiantan Biological Products Intravenous Injection Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Beijing Tiantan Biological Products Intravenous Injection Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Beijing Tiantan Biological Products Recent Developments
    11.3 Hualan Bio
        11.3.1 Hualan Bio Corporation Information
        11.3.2 Hualan Bio Overview
        11.3.3 Hualan Bio Intravenous Injection Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Hualan Bio Intravenous Injection Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Hualan Bio Recent Developments
    11.4 Guangdong Shuagnlin Bio-pharmacy
        11.4.1 Guangdong Shuagnlin Bio-pharmacy Corporation Information
        11.4.2 Guangdong Shuagnlin Bio-pharmacy Overview
        11.4.3 Guangdong Shuagnlin Bio-pharmacy Intravenous Injection Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Guangdong Shuagnlin Bio-pharmacy Intravenous Injection Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Guangdong Shuagnlin Bio-pharmacy Recent Developments
    11.5 Weiguang Biological
        11.5.1 Weiguang Biological Corporation Information
        11.5.2 Weiguang Biological Overview
        11.5.3 Weiguang Biological Intravenous Injection Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Weiguang Biological Intravenous Injection Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Weiguang Biological Recent Developments
    11.6 Sinopharm
        11.6.1 Sinopharm Corporation Information
        11.6.2 Sinopharm Overview
        11.6.3 Sinopharm Intravenous Injection Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Sinopharm Intravenous Injection Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Sinopharm Recent Developments
    11.7 Shanghai RAAS
        11.7.1 Shanghai RAAS Corporation Information
        11.7.2 Shanghai RAAS Overview
        11.7.3 Shanghai RAAS Intravenous Injection Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Shanghai RAAS Intravenous Injection Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Shanghai RAAS Recent Developments
    11.8 CTBB
        11.8.1 CTBB Corporation Information
        11.8.2 CTBB Overview
        11.8.3 CTBB Intravenous Injection Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 CTBB Intravenous Injection Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 CTBB Recent Developments
    11.9 Nanyue Biopharming
        11.9.1 Nanyue Biopharming Corporation Information
        11.9.2 Nanyue Biopharming Overview
        11.9.3 Nanyue Biopharming Intravenous Injection Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Nanyue Biopharming Intravenous Injection Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Nanyue Biopharming Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Intravenous Injection Immunoglobulin Industry Chain Analysis
    12.2 Intravenous Injection Immunoglobulin Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Intravenous Injection Immunoglobulin Production Mode & Process
    12.4 Intravenous Injection Immunoglobulin Sales and Marketing
        12.4.1 Intravenous Injection Immunoglobulin Sales Channels
        12.4.2 Intravenous Injection Immunoglobulin Distributors
    12.5 Intravenous Injection Immunoglobulin Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Intravenous Injection Immunoglobulin Industry Trends
    13.2 Intravenous Injection Immunoglobulin Market Drivers
    13.3 Intravenous Injection Immunoglobulin Market Challenges
    13.4 Intravenous Injection Immunoglobulin Market Restraints
14 Key Findings in The Global Intravenous Injection Immunoglobulin Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Intravenous Injection Immunoglobulin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of 1g/20ml
    Table 3. Major Manufacturers of 1.25g/25ml
    Table 4. Major Manufacturers of 2.5g/50ml
    Table 5. Major Manufacturers of 5g/100ml
    Table 6. Major Manufacturers of 10g/200ml
    Table 7. Global Intravenous Injection Immunoglobulin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Intravenous Injection Immunoglobulin Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 9. Global Intravenous Injection Immunoglobulin Sales by Region (2017-2022) & (L)
    Table 10. Global Intravenous Injection Immunoglobulin Sales Market Share by Region (2017-2022)
    Table 11. Global Intravenous Injection Immunoglobulin Sales by Region (2023-2028) & (L)
    Table 12. Global Intravenous Injection Immunoglobulin Sales Market Share by Region (2023-2028)
    Table 13. Global Intravenous Injection Immunoglobulin Revenue by Region (2017-2022) & (US$ Million)
    Table 14. Global Intravenous Injection Immunoglobulin Revenue Market Share by Region (2017-2022)
    Table 15. Global Intravenous Injection Immunoglobulin Revenue by Region (2023-2028) & (US$ Million)
    Table 16. Global Intravenous Injection Immunoglobulin Revenue Market Share by Region (2023-2028)
    Table 17. Global Intravenous Injection Immunoglobulin Sales by Manufacturers (2017-2022) & (L)
    Table 18. Global Intravenous Injection Immunoglobulin Sales Share by Manufacturers (2017-2022)
    Table 19. Global Intravenous Injection Immunoglobulin Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 20. Global Intravenous Injection Immunoglobulin Revenue Share by Manufacturers (2017-2022)
    Table 21. Intravenous Injection Immunoglobulin Price by Manufacturers (2017-2022) &(US$/ml)
    Table 22. Global Intravenous Injection Immunoglobulin Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Intravenous Injection Immunoglobulin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous Injection Immunoglobulin as of 2021)
    Table 24. Intravenous Injection Immunoglobulin Manufacturing Base Distribution and Headquarters
    Table 25. Manufacturers Intravenous Injection Immunoglobulin Product Offered
    Table 26. Date of Manufacturers Enter into Intravenous Injection Immunoglobulin Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Intravenous Injection Immunoglobulin Sales by Type (2017-2022) & (L)
    Table 29. Global Intravenous Injection Immunoglobulin Sales by Type (2023-2028) & (L)
    Table 30. Global Intravenous Injection Immunoglobulin Sales Share by Type (2017-2022)
    Table 31. Global Intravenous Injection Immunoglobulin Sales Share by Type (2023-2028)
    Table 32. Global Intravenous Injection Immunoglobulin Revenue by Type (2017-2022) & (US$ Million)
    Table 33. Global Intravenous Injection Immunoglobulin Revenue by Type (2023-2028) & (US$ Million)
    Table 34. Global Intravenous Injection Immunoglobulin Revenue Share by Type (2017-2022)
    Table 35. Global Intravenous Injection Immunoglobulin Revenue Share by Type (2023-2028)
    Table 36. Intravenous Injection Immunoglobulin Price by Type (2017-2022) & (US$/ml)
    Table 37. Global Intravenous Injection Immunoglobulin Price Forecast by Type (2023-2028) & (US$/ml)
    Table 38. Global Intravenous Injection Immunoglobulin Sales by Application (2017-2022) & (L)
    Table 39. Global Intravenous Injection Immunoglobulin Sales by Application (2023-2028) & (L)
    Table 40. Global Intravenous Injection Immunoglobulin Sales Share by Application (2017-2022)
    Table 41. Global Intravenous Injection Immunoglobulin Sales Share by Application (2023-2028)
    Table 42. Global Intravenous Injection Immunoglobulin Revenue by Application (2017-2022) & (US$ Million)
    Table 43. Global Intravenous Injection Immunoglobulin Revenue by Application (2023-2028) & (US$ Million)
    Table 44. Global Intravenous Injection Immunoglobulin Revenue Share by Application (2017-2022)
    Table 45. Global Intravenous Injection Immunoglobulin Revenue Share by Application (2023-2028)
    Table 46. Intravenous Injection Immunoglobulin Price by Application (2017-2022) & (US$/ml)
    Table 47. Global Intravenous Injection Immunoglobulin Price Forecast by Application (2023-2028) & (US$/ml)
    Table 48. North America Intravenous Injection Immunoglobulin Sales by Type (2017-2022) & (L)
    Table 49. North America Intravenous Injection Immunoglobulin Sales by Type (2023-2028) & (L)
    Table 50. North America Intravenous Injection Immunoglobulin Revenue by Type (2017-2022) & (US$ Million)
    Table 51. North America Intravenous Injection Immunoglobulin Revenue by Type (2023-2028) & (US$ Million)
    Table 52. North America Intravenous Injection Immunoglobulin Sales by Application (2017-2022) & (L)
    Table 53. North America Intravenous Injection Immunoglobulin Sales by Application (2023-2028) & (L)
    Table 54. North America Intravenous Injection Immunoglobulin Revenue by Application (2017-2022) & (US$ Million)
    Table 55. North America Intravenous Injection Immunoglobulin Revenue by Application (2023-2028) & (US$ Million)
    Table 56. North America Intravenous Injection Immunoglobulin Sales by Country (2017-2022) & (L)
    Table 57. North America Intravenous Injection Immunoglobulin Sales by Country (2023-2028) & (L)
    Table 58. North America Intravenous Injection Immunoglobulin Revenue by Country (2017-2022) & (US$ Million)
    Table 59. North America Intravenous Injection Immunoglobulin Revenue by Country (2023-2028) & (US$ Million)
    Table 60. Europe Intravenous Injection Immunoglobulin Sales by Type (2017-2022) & (L)
    Table 61. Europe Intravenous Injection Immunoglobulin Sales by Type (2023-2028) & (L)
    Table 62. Europe Intravenous Injection Immunoglobulin Revenue by Type (2017-2022) & (US$ Million)
    Table 63. Europe Intravenous Injection Immunoglobulin Revenue by Type (2023-2028) & (US$ Million)
    Table 64. Europe Intravenous Injection Immunoglobulin Sales by Application (2017-2022) & (L)
    Table 65. Europe Intravenous Injection Immunoglobulin Sales by Application (2023-2028) & (L)
    Table 66. Europe Intravenous Injection Immunoglobulin Revenue by Application (2017-2022) & (US$ Million)
    Table 67. Europe Intravenous Injection Immunoglobulin Revenue by Application (2023-2028) & (US$ Million)
    Table 68. Europe Intravenous Injection Immunoglobulin Sales by Country (2017-2022) & (L)
    Table 69. Europe Intravenous Injection Immunoglobulin Sales by Country (2023-2028) & (L)
    Table 70. Europe Intravenous Injection Immunoglobulin Revenue by Country (2017-2022) & (US$ Million)
    Table 71. Europe Intravenous Injection Immunoglobulin Revenue by Country (2023-2028) & (US$ Million)
    Table 72. Asia Pacific Intravenous Injection Immunoglobulin Sales by Type (2017-2022) & (L)
    Table 73. Asia Pacific Intravenous Injection Immunoglobulin Sales by Type (2023-2028) & (L)
    Table 74. Asia Pacific Intravenous Injection Immunoglobulin Revenue by Type (2017-2022) & (US$ Million)
    Table 75. Asia Pacific Intravenous Injection Immunoglobulin Revenue by Type (2023-2028) & (US$ Million)
    Table 76. Asia Pacific Intravenous Injection Immunoglobulin Sales by Application (2017-2022) & (L)
    Table 77. Asia Pacific Intravenous Injection Immunoglobulin Sales by Application (2023-2028) & (L)
    Table 78. Asia Pacific Intravenous Injection Immunoglobulin Revenue by Application (2017-2022) & (US$ Million)
    Table 79. Asia Pacific Intravenous Injection Immunoglobulin Revenue by Application (2023-2028) & (US$ Million)
    Table 80. Asia Pacific Intravenous Injection Immunoglobulin Sales by Region (2017-2022) & (L)
    Table 81. Asia Pacific Intravenous Injection Immunoglobulin Sales by Region (2023-2028) & (L)
    Table 82. Asia Pacific Intravenous Injection Immunoglobulin Revenue by Region (2017-2022) & (US$ Million)
    Table 83. Asia Pacific Intravenous Injection Immunoglobulin Revenue by Region (2023-2028) & (US$ Million)
    Table 84. Latin America Intravenous Injection Immunoglobulin Sales by Type (2017-2022) & (L)
    Table 85. Latin America Intravenous Injection Immunoglobulin Sales by Type (2023-2028) & (L)
    Table 86. Latin America Intravenous Injection Immunoglobulin Revenue by Type (2017-2022) & (US$ Million)
    Table 87. Latin America Intravenous Injection Immunoglobulin Revenue by Type (2023-2028) & (US$ Million)
    Table 88. Latin America Intravenous Injection Immunoglobulin Sales by Application (2017-2022) & (L)
    Table 89. Latin America Intravenous Injection Immunoglobulin Sales by Application (2023-2028) & (L)
    Table 90. Latin America Intravenous Injection Immunoglobulin Revenue by Application (2017-2022) & (US$ Million)
    Table 91. Latin America Intravenous Injection Immunoglobulin Revenue by Application (2023-2028) & (US$ Million)
    Table 92. Latin America Intravenous Injection Immunoglobulin Sales by Country (2017-2022) & (L)
    Table 93. Latin America Intravenous Injection Immunoglobulin Sales by Country (2023-2028) & (L)
    Table 94. Latin America Intravenous Injection Immunoglobulin Revenue by Country (2017-2022) & (US$ Million)
    Table 95. Latin America Intravenous Injection Immunoglobulin Revenue by Country (2023-2028) & (US$ Million)
    Table 96. Middle East and Africa Intravenous Injection Immunoglobulin Sales by Type (2017-2022) & (L)
    Table 97. Middle East and Africa Intravenous Injection Immunoglobulin Sales by Type (2023-2028) & (L)
    Table 98. Middle East and Africa Intravenous Injection Immunoglobulin Revenue by Type (2017-2022) & (US$ Million)
    Table 99. Middle East and Africa Intravenous Injection Immunoglobulin Revenue by Type (2023-2028) & (US$ Million)
    Table 100. Middle East and Africa Intravenous Injection Immunoglobulin Sales by Application (2017-2022) & (L)
    Table 101. Middle East and Africa Intravenous Injection Immunoglobulin Sales by Application (2023-2028) & (L)
    Table 102. Middle East and Africa Intravenous Injection Immunoglobulin Revenue by Application (2017-2022) & (US$ Million)
    Table 103. Middle East and Africa Intravenous Injection Immunoglobulin Revenue by Application (2023-2028) & (US$ Million)
    Table 104. Middle East and Africa Intravenous Injection Immunoglobulin Sales by Country (2017-2022) & (L)
    Table 105. Middle East and Africa Intravenous Injection Immunoglobulin Sales by Country (2023-2028) & (L)
    Table 106. Middle East and Africa Intravenous Injection Immunoglobulin Revenue by Country (2017-2022) & (US$ Million)
    Table 107. Middle East and Africa Intravenous Injection Immunoglobulin Revenue by Country (2023-2028) & (US$ Million)
    Table 108. Boya-Bio Corporation Information
    Table 109. Boya-Bio Description and Major Businesses
    Table 110. Boya-Bio Intravenous Injection Immunoglobulin Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2017-2022)
    Table 111. Boya-Bio Intravenous Injection Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. Boya-Bio Recent Developments
    Table 113. Beijing Tiantan Biological Products Corporation Information
    Table 114. Beijing Tiantan Biological Products Description and Major Businesses
    Table 115. Beijing Tiantan Biological Products Intravenous Injection Immunoglobulin Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2017-2022)
    Table 116. Beijing Tiantan Biological Products Intravenous Injection Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. Beijing Tiantan Biological Products Recent Developments
    Table 118. Hualan Bio Corporation Information
    Table 119. Hualan Bio Description and Major Businesses
    Table 120. Hualan Bio Intravenous Injection Immunoglobulin Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2017-2022)
    Table 121. Hualan Bio Intravenous Injection Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. Hualan Bio Recent Developments
    Table 123. Guangdong Shuagnlin Bio-pharmacy Corporation Information
    Table 124. Guangdong Shuagnlin Bio-pharmacy Description and Major Businesses
    Table 125. Guangdong Shuagnlin Bio-pharmacy Intravenous Injection Immunoglobulin Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2017-2022)
    Table 126. Guangdong Shuagnlin Bio-pharmacy Intravenous Injection Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. Guangdong Shuagnlin Bio-pharmacy Recent Developments
    Table 128. Weiguang Biological Corporation Information
    Table 129. Weiguang Biological Description and Major Businesses
    Table 130. Weiguang Biological Intravenous Injection Immunoglobulin Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2017-2022)
    Table 131. Weiguang Biological Intravenous Injection Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 132. Weiguang Biological Recent Developments
    Table 133. Sinopharm Corporation Information
    Table 134. Sinopharm Description and Major Businesses
    Table 135. Sinopharm Intravenous Injection Immunoglobulin Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2017-2022)
    Table 136. Sinopharm Intravenous Injection Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 137. Sinopharm Recent Developments
    Table 138. Shanghai RAAS Corporation Information
    Table 139. Shanghai RAAS Description and Major Businesses
    Table 140. Shanghai RAAS Intravenous Injection Immunoglobulin Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2017-2022)
    Table 141. Shanghai RAAS Intravenous Injection Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 142. Shanghai RAAS Recent Developments
    Table 143. CTBB Corporation Information
    Table 144. CTBB Description and Major Businesses
    Table 145. CTBB Intravenous Injection Immunoglobulin Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2017-2022)
    Table 146. CTBB Intravenous Injection Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 147. CTBB Recent Developments
    Table 148. Nanyue Biopharming Corporation Information
    Table 149. Nanyue Biopharming Description and Major Businesses
    Table 150. Nanyue Biopharming Intravenous Injection Immunoglobulin Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2017-2022)
    Table 151. Nanyue Biopharming Intravenous Injection Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 152. Nanyue Biopharming Recent Developments
    Table 153. Key Raw Materials Lists
    Table 154. Raw Materials Key Suppliers Lists
    Table 155. Intravenous Injection Immunoglobulin Distributors List
    Table 156. Intravenous Injection Immunoglobulin Customers List
    Table 157. Intravenous Injection Immunoglobulin Market Trends
    Table 158. Intravenous Injection Immunoglobulin Market Drivers
    Table 159. Intravenous Injection Immunoglobulin Market Challenges
    Table 160. Intravenous Injection Immunoglobulin Market Restraints
    Table 161. Research Programs/Design for This Report
    Table 162. Key Data Information from Secondary Sources
    Table 163. Key Data Information from Primary Sources
List of Figures
    Figure 1. Intravenous Injection Immunoglobulin Product Picture
    Figure 3. Global Intravenous Injection Immunoglobulin Market Share by Type in 2021 & 2028
    Figure 3. 1g/20ml Product Picture
    Figure 4. 1.25g/25ml Product Picture
    Figure 5. 2.5g/50ml Product Picture
    Figure 6. 5g/100ml Product Picture
    Figure 7. 10g/200ml Product Picture
    Figure 8. Global Intravenous Injection Immunoglobulin Market Share by Application in 2021 & 2028
    Figure 9. Hospital
    Figure 10. Clinic
    Figure 11. Others
    Figure 12. Intravenous Injection Immunoglobulin Report Years Considered
    Figure 13. Global Intravenous Injection Immunoglobulin Sales 2017-2028 (L)
    Figure 14. Global Intravenous Injection Immunoglobulin Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Intravenous Injection Immunoglobulin Revenue 2017-2028 (US$ Million)
    Figure 16. Global Intravenous Injection Immunoglobulin Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 17. Global Intravenous Injection Immunoglobulin Sales Market Share by Region (2017-2022)
    Figure 18. Global Intravenous Injection Immunoglobulin Sales Market Share by Region (2023-2028)
    Figure 19. North America Intravenous Injection Immunoglobulin Sales YoY (2017-2028) & (L)
    Figure 20. North America Intravenous Injection Immunoglobulin Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Europe Intravenous Injection Immunoglobulin Sales YoY (2017-2028) & (L)
    Figure 22. Europe Intravenous Injection Immunoglobulin Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Asia-Pacific Intravenous Injection Immunoglobulin Sales YoY (2017-2028) & (L)
    Figure 24. Asia-Pacific Intravenous Injection Immunoglobulin Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Latin America Intravenous Injection Immunoglobulin Sales YoY (2017-2028) & (L)
    Figure 26. Latin America Intravenous Injection Immunoglobulin Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. Middle East & Africa Intravenous Injection Immunoglobulin Sales YoY (2017-2028) & (L)
    Figure 28. Middle East & Africa Intravenous Injection Immunoglobulin Revenue YoY (2017-2028) & (US$ Million)
    Figure 29. The Intravenous Injection Immunoglobulin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 30. The Top 5 and 10 Largest Manufacturers of Intravenous Injection Immunoglobulin in the World: Market Share by Intravenous Injection Immunoglobulin Revenue in 2021
    Figure 31. Global Intravenous Injection Immunoglobulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 32. Global Intravenous Injection Immunoglobulin Sales Market Share by Type (2017-2028)
    Figure 33. Global Intravenous Injection Immunoglobulin Revenue Market Share by Type (2017-2028)
    Figure 34. Global Intravenous Injection Immunoglobulin Sales Market Share by Application (2017-2028)
    Figure 35. Global Intravenous Injection Immunoglobulin Revenue Market Share by Application (2017-2028)
    Figure 36. North America Intravenous Injection Immunoglobulin Sales Market Share by Type (2017-2028)
    Figure 37. North America Intravenous Injection Immunoglobulin Revenue Market Share by Type (2017-2028)
    Figure 38. North America Intravenous Injection Immunoglobulin Sales Market Share by Application (2017-2028)
    Figure 39. North America Intravenous Injection Immunoglobulin Revenue Market Share by Application (2017-2028)
    Figure 40. North America Intravenous Injection Immunoglobulin Sales Share by Country (2017-2028)
    Figure 41. North America Intravenous Injection Immunoglobulin Revenue Share by Country (2017-2028)
    Figure 42. U.S. Intravenous Injection Immunoglobulin Revenue (2017-2028) & (US$ Million)
    Figure 43. Canada Intravenous Injection Immunoglobulin Revenue (2017-2028) & (US$ Million)
    Figure 44. Europe Intravenous Injection Immunoglobulin Sales Market Share by Type (2017-2028)
    Figure 45. Europe Intravenous Injection Immunoglobulin Revenue Market Share by Type (2017-2028)
    Figure 46. Europe Intravenous Injection Immunoglobulin Sales Market Share by Application (2017-2028)
    Figure 47. Europe Intravenous Injection Immunoglobulin Revenue Market Share by Application (2017-2028)
    Figure 48. Europe Intravenous Injection Immunoglobulin Sales Share by Country (2017-2028)
    Figure 49. Europe Intravenous Injection Immunoglobulin Revenue Share by Country (2017-2028)
    Figure 50. Germany Intravenous Injection Immunoglobulin Revenue (2017-2028) & (US$ Million)
    Figure 51. France Intravenous Injection Immunoglobulin Revenue (2017-2028) & (US$ Million)
    Figure 52. U.K. Intravenous Injection Immunoglobulin Revenue (2017-2028) & (US$ Million)
    Figure 53. Italy Intravenous Injection Immunoglobulin Revenue (2017-2028) & (US$ Million)
    Figure 54. Russia Intravenous Injection Immunoglobulin Revenue (2017-2028) & (US$ Million)
    Figure 55. Asia Pacific Intravenous Injection Immunoglobulin Sales Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Intravenous Injection Immunoglobulin Revenue Market Share by Type (2017-2028)
    Figure 57. Asia Pacific Intravenous Injection Immunoglobulin Sales Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Intravenous Injection Immunoglobulin Revenue Market Share by Application (2017-2028)
    Figure 59. Asia Pacific Intravenous Injection Immunoglobulin Sales Share by Region (2017-2028)
    Figure 60. Asia Pacific Intravenous Injection Immunoglobulin Revenue Share by Region (2017-2028)
    Figure 61. China Intravenous Injection Immunoglobulin Revenue (2017-2028) & (US$ Million)
    Figure 62. Japan Intravenous Injection Immunoglobulin Revenue (2017-2028) & (US$ Million)
    Figure 63. South Korea Intravenous Injection Immunoglobulin Revenue (2017-2028) & (US$ Million)
    Figure 64. India Intravenous Injection Immunoglobulin Revenue (2017-2028) & (US$ Million)
    Figure 65. Australia Intravenous Injection Immunoglobulin Revenue (2017-2028) & (US$ Million)
    Figure 66. Taiwan Intravenous Injection Immunoglobulin Revenue (2017-2028) & (US$ Million)
    Figure 67. Indonesia Intravenous Injection Immunoglobulin Revenue (2017-2028) & (US$ Million)
    Figure 68. Thailand Intravenous Injection Immunoglobulin Revenue (2017-2028) & (US$ Million)
    Figure 69. Malaysia Intravenous Injection Immunoglobulin Revenue (2017-2028) & (US$ Million)
    Figure 70. Philippines Intravenous Injection Immunoglobulin Revenue (2017-2028) & (US$ Million)
    Figure 71. Latin America Intravenous Injection Immunoglobulin Sales Market Share by Type (2017-2028)
    Figure 72. Latin America Intravenous Injection Immunoglobulin Revenue Market Share by Type (2017-2028)
    Figure 73. Latin America Intravenous Injection Immunoglobulin Sales Market Share by Application (2017-2028)
    Figure 74. Latin America Intravenous Injection Immunoglobulin Revenue Market Share by Application (2017-2028)
    Figure 75. Latin America Intravenous Injection Immunoglobulin Sales Share by Country (2017-2028)
    Figure 76. Latin America Intravenous Injection Immunoglobulin Revenue Share by Country (2017-2028)
    Figure 77. Mexico Intravenous Injection Immunoglobulin Revenue (2017-2028) & (US$ Million)
    Figure 78. Brazil Intravenous Injection Immunoglobulin Revenue (2017-2028) & (US$ Million)
    Figure 79. Argentina Intravenous Injection Immunoglobulin Revenue (2017-2028) & (US$ Million)
    Figure 80. Middle East and Africa Intravenous Injection Immunoglobulin Sales Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Intravenous Injection Immunoglobulin Revenue Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa Intravenous Injection Immunoglobulin Sales Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Intravenous Injection Immunoglobulin Revenue Market Share by Application (2017-2028)
    Figure 84. Middle East and Africa Intravenous Injection Immunoglobulin Sales Share by Country (2017-2028)
    Figure 85. Middle East and Africa Intravenous Injection Immunoglobulin Revenue Share by Country (2017-2028)
    Figure 86. Turkey Intravenous Injection Immunoglobulin Revenue (2017-2028) & (US$ Million)
    Figure 87. Saudi Arabia Intravenous Injection Immunoglobulin Revenue (2017-2028) & (US$ Million)
    Figure 88. UAE Intravenous Injection Immunoglobulin Revenue (2017-2028) & (US$ Million)
    Figure 89. Intravenous Injection Immunoglobulin Value Chain
    Figure 90. Intravenous Injection Immunoglobulin Production Process
    Figure 91. Channels of Distribution
    Figure 92. Distributors Profiles
    Figure 93. Bottom-up and Top-down Approaches for This Report
    Figure 94. Data Triangulation
    Figure 95. Key Executives Interviewed